Three Lymphadenectomy Strategies in Low-Risk Endometrial Carcinoma: A Cost-effectiveness Analysis

Medicine & Life Sciences

• Endometrial Neoplasms 100%
• Lymph Node Excision 95%
• Cost-Benefit Analysis 84%
• Sentinel Lymph Node 37%
• Costs and Cost Analysis 31%
• Lymphedema 30%
• Survival 8%
• Quality of Life 6%
• Decision Support Techniques 6%
• Minimally Invasive Surgical Procedures 5%
• Frozen Sections 5%
• Medicare 5%
• Operating Rooms 5%
• Standard of Care 4%
• Health Care Costs 4%
• Lower Extremity 4%
• Histology 4%
• Pathology 3%
• Physicians 3%
• Biopsy 3%
• Morbidity 3%
• Therapeutics 0%